Superworth

Cytosorbents EPS CTSO

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$5.80
Latest quarter, Q2 FY26
−$1.40
−333% on a year earlier
Fiscal year 2025
−$2.60

Cytosorbents' earnings per share was −$5.80 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.40, down 333% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.60n/a
FY2024−$7.60n/a
FY2023−$12.80n/a
FY2022−$15.20n/a
FY2021−$10.80n/a
FY2020−$4.00n/a
FY2019−$12.00n/a
FY2018−$11.20n/a
FY2017−$6.40n/a
FY2016−$9.20n/a
FY2015−$7.40n/a
FY2014−$23.20n/a
FY2013−$20.00n/a
FY2012−$20.00n/a
FY2011−$20.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.40−333%−$5.80
Q1 FY26−$1.60n/a−$3.80
Q4 FY25−$1.80n/a−$2.60
Q3 FY25−$1.00n/a−$3.60
Q2 FY25$0.60n/a−$3.60
Q1 FY25−$0.40n/a−$5.80
Q4 FY24−$2.80n/a−$7.60
Q3 FY24−$1.00n/a−$7.20
Q2 FY24−$1.60n/a−$10.40
Q1 FY24−$2.20n/a−$11.60
Q4 FY23−$2.40n/a−$12.80
Q3 FY23−$4.20n/a−$10.80

Against its peers

Companies in Medical - Instruments & Supplies nearest Cytosorbents' size, closest first, today.

CompanyEPS, 12 monthsGrowth
CTSOCytosorbents−$5.80
NEPHNephros$0.16+33% a year
APTAlpha Pro Tech$0.41+24% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.41

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cytosorbents

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.